Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1
- PMID: 11473421
- DOI: 10.1021/np010049y
Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1
Abstract
The potent antitumor agent dolastatin 10 (1) was originally isolated from the sea hare Dolabella auricularia, and we now report its isolation from the marine cyanobacterium Symploca sp. VP642 from Palau. The chemically related analogue symplostatin 1 (2) has been reisolated from Guamanian and Hawaiian varieties of S. hydnoides and its total stereochemistry completed by determining the N,N-dimethylisoleucine unit to be L. Symplostatin 1 (2), like dolastatin 10 (1), is a potent microtubule inhibitor. The antitumor activity of 2 was assessed in vivo against several murine tumors. Symplostatin 1 (2) was effective against a drug-insensitive mammary tumor and a drug-insensitive colon tumor; however, it was only slightly effective against two MDR tumors.
Similar articles
-
Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.J Nat Prod. 1998 Sep;61(9):1075-7. doi: 10.1021/np980321c. J Nat Prod. 1998. PMID: 9748368
-
Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoides.J Nat Prod. 1999 Apr;62(4):655-8. doi: 10.1021/np980553b. J Nat Prod. 1999. PMID: 10217737
-
Symplostatin 3, a new dolastatin 10 analogue from the marine cyanobacterium Symploca sp. VP452.J Nat Prod. 2002 Jan;65(1):16-20. doi: 10.1021/np010317s. J Nat Prod. 2002. PMID: 11809057
-
The cyanobacterial origin of potent anticancer agents originally isolated from sea hares.Curr Med Chem. 2002 Oct;9(20):1791-806. doi: 10.2174/0929867023369051. Curr Med Chem. 2002. PMID: 12369878 Review.
-
The dolastatins, a family of promising antineoplastic agents.Curr Pharm Des. 1999 Mar;5(3):139-62. Curr Pharm Des. 1999. PMID: 10066887 Review.
Cited by
-
An Updated Review on Marine Anticancer Compounds: The Use of Virtual Screening for the Discovery of Small-Molecule Cancer Drugs.Molecules. 2017 Jun 23;22(7):1037. doi: 10.3390/molecules22071037. Molecules. 2017. PMID: 28644406 Free PMC article. Review.
-
Antimalarial linear lipopeptides from a Panamanian strain of the marine cyanobacterium Lyngbya majuscula.J Nat Prod. 2007 Jun;70(6):984-8. doi: 10.1021/np0700772. Epub 2007 Apr 19. J Nat Prod. 2007. PMID: 17441769 Free PMC article.
-
Multifaceted Marine Peptides and Their Therapeutic Potential.Mar Drugs. 2025 Jul 15;23(7):288. doi: 10.3390/md23070288. Mar Drugs. 2025. PMID: 40710513 Free PMC article. Review.
-
Recent Advances in Cyanotoxin Synthesis and Applications: A Comprehensive Review.Microorganisms. 2023 Oct 26;11(11):2636. doi: 10.3390/microorganisms11112636. Microorganisms. 2023. PMID: 38004647 Free PMC article. Review.
-
New Nostocyclophanes from Nostoc linckia.Mar Drugs. 2023 Jan 31;21(2):101. doi: 10.3390/md21020101. Mar Drugs. 2023. PMID: 36827142 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous